August 1997
Clinical & Investigative Medicine;Aug97 Supplement, Vol. 20, pS33
Academic Journal
Presents an abstract of the research manuscript `Autologous marrow or blood cell transplantation in patients > 60 years of age,' by C. Leger, C. Bredeson et al from the Ottawa General Hospital Blood and Marrow Transplant Program.


Related Articles

  • Marrow repopulating cells in mobilized PBPC can be serially transplanted for up to five generations or be remobilized in PBPC reconstituted mice. Yan, X.Q.; Chen, Y.; Hartley, C.; McElroy, P.; Fletcher, F.; McNiece, I.K. // Bone Marrow Transplantation;5/15/98, Vol. 21 Issue 10, p975 

    We have evaluated the durability of engraftment and the potential of remobilization in mice reconstituted with mobilized peripheral blood progenitor cells (PBPC). Female mice which had been reconstituted with cytokine-mobilized PBPC from male donors were serially transplanted into second, third,...

  • Long-lasting decrease of marrow and circulating long-term culture initiating cells after allogeneic bone marrow transplant. Selleri, C; Maciejewski, J P; De Rosa, G; Raiola, A; Risitano, A M; Picardi, M; Pezzullo, L; Luciano, L; Ricci, P; Varriale, G; Della Cioppa, P; Del Vecchio, L; Rotoli, B // Bone Marrow Transplantation;5/15/99, Vol. 23 Issue 10, p1029 

    We investigated bone marrow (BM) and circulating (PB) hematopoietic progenitor cells in 37 normal donors and in 25 patients 1 to 8 years after successful allogeneic bone marrow transplant. At the time of testing, transplanted patients had normal blood counts and bone marrow cellularity. By flow...

  • Successful treatment of post-transplant lymphoproliferative disorder in autologous blood stem cell transplant recipients. Jenkins, D.; DiFrancesco, L.; Chaudhry, A.; Morris, D.; Gluck, S.; Jones, A.; Woodman, R.; Brown, C. B.; Russell, J.; Stewart, D. A. // Bone Marrow Transplantation;9/1/2002, Vol. 30 Issue 5, p321 

    Presents a study that examined post-transplant lymphoproliferative disorder (PTLD) in the context of autologous stem cell transplantation (ASCT) for multiple myeloma and non-Hodgkin's lymphoma. Complications after solid organ transplant and bone marrow transplantation; Mortality rate of...

  • A rare find - cells that improve bone marrow transplantation. Li, Xian Chang; Strom, Terry B. // Nature Medicine;Aug2000, Vol. 6 Issue 8, p866 

    Focuses on the improvement of bone marrow transplantation by facilitating cells. Promotion of hematopoietic stem cell engraftment by the facilitating cells; Role of facilitating cells in solid organ transplantation; Identification of facilitating cells in bone marrow by cell surface makers and ...

  • IL-4-producing CD8+ T cells may be an immunological hallmark of chronic GVHD. Nakamura, K.; Amakawa, R.; Takebayashi, M.; Son, Y.; Miyaji, M.; Tajima, K.; Nakai, K.; Ito, T.; Matsumoto, N.; Zen, K.; Kishimoto, Y.; Fukuhara, S. // Bone Marrow Transplantation;Oct2005, Vol. 36 Issue 7, p639 

    Summary:Chronic graft-versus-host disease (cGVHD) occurs in approximately 60–80% of those who survive over 100 days after allogeneic hematopoietic stem cell transplantation (allo-HSCT). However, the pathophysiology of cGVHD is poorly understood. To gain more insight into the immunological...

  • Hematopoietic stem cell transplantation for autoimmune diseases in developing countries: current status and future prospectives. Voltarelli, J C; Ouyang, J // Bone Marrow Transplantation;Aug2003 Supplement 1, Vol. 32 Issue 1, pS69 

    Summary:In this paper we present preliminary results of hematopoietic stem cell transplantation for autoimmune diseases in Brazil and China. Chinese experience transplanting lupus is significant and the Brazilian experience with several autoimmune diseases is growing. We discuss peculiar...

  • Influence of conditioning regimens and stem cell sources on donor-type chimerism early after stem cell transplantation. Sugita, Junichi; Tanaka, Junji; Hashimoto, Aya; Shiratori, Souichi; Yasumoto, Atsushi; Wakasa, Kentaro; Kikuchi, Misato; Shigematsu, Akio; Miura, Yoko; Tsutsumi, Yutaka; Kondo, Takeshi; Asaka, Masahiro; Imamura, Masahiro // Annals of Hematology;Dec2008, Vol. 87 Issue 12, p1003 

    We retrospectively analyzed very early chimerism before and ongoing neutrophil engraftment (days 7, 14, 21, 28) and investigated the influence of conditioning regimens and stem cell sources on donor-type chimerism in 59 Japanese patients who had received allogeneic hematopoietic stem cell...

  • Early allogeneic blood stem cell transplantation after modified conditioning therapy during marrow aplasia: stable remission in high-risk acute myeloid leukemia. Platzbecker, U; Thiede, C; Freiberg-Richter, J; Röllig, C; Helwig, A; Schäkel, U; Mohr, B; Schaich, M; Ehninger, G; Bornhäuser, M // Bone Marrow Transplantation;3/1/2001, Vol. 27 Issue 5, p543 

    Two patients with high-risk acute myeloid leukemia (AML) whose bone marrow aspirates showed more than 25% blasts between 2 and 4 weeks after the first induction chemotherapy immediately received modified conditioning therapy with intravenous busulfan at 50% of the usual dose and fludarabine,...

  • Prognostic importance of the platelet count 100 days post allogeneic bone marrow transplant. Bolwell, B.; Pohlman, B.; Sobecks, R.; Andresen, S.; Brown, S.; Rybicki, L.; Wentling, V.; Kalaycio, M. // Bone Marrow Transplantation;Feb2004, Vol. 33 Issue 4, p419 

    Summary:We assessed the prognostic importance of the platelet count 100 days post transplant of 107 consecutive patients receiving ablative allogeneic bone marrow transplant (BMT) between 7/96 and 12/00 who survived at least 100 days. Diagnoses included AML (n=36), chronic myelogenous leukemia...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics